Published in Rev Med Univ Navarra on December 03, 1976
Cuban programme for prevention of sickle cell disease. Lancet (1991) 1.43
[Clinical factors associated with bone mass loss previous cardiac transplantation]. Med Clin (Barc) (2000) 1.41
[Comparative study of high-frequency jet ventilation in 4 types of patients undergoing laryngeal microsurgery]. Rev Esp Anestesiol Reanim (1997) 1.38
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect (2005) 1.27
Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci Res (2001) 1.15
Dielectric characterization of bacterial cells using dielectrophoresis. Bioelectromagnetics (2007) 1.11
[Percutaneous mitral valvuloplasty. Immediate results with the 30 mm diameter dilatation balloon]. Rev Esp Cardiol (1992) 1.09
Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial. J Viral Hepat (2008) 1.07
[Protein quality of three strains of Mexican mushrooms (Pleurotus ostreatus)]. Arch Latinoam Nutr (1999) 1.01
[Synchronous diagnosis of small-cell lung cancer and Hodgkin lymphoma]. An Med Interna (2006) 1.00
Electrostatic modeling of dipole-ion interactions in gramicidinlike channels. Biophys J (1991) 1.00
Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study. Rev Esp Quimioter (2007) 0.97
Effect of bromochloromethane on methane emission, rumen fermentation pattern, milk yield, and fatty acid profile in lactating dairy goats. J Dairy Sci (2012) 0.94
The PCR-based detection of Trypanosoma cruzi in the faeces of Triatoma infestans fed on patients with chronic American trypanosomiasis gives higher sensitivity and a quicker result than routine xenodiagnosis. Ann Trop Med Parasitol (2007) 0.94
Nimesulide limits kainate-induced oxidative damage in the rat hippocampus. Eur J Pharmacol (2000) 0.93
Mode of action of Buddleja cordata verbascoside against Staphylococcus aureus. J Ethnopharmacol (1999) 0.93
Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res (2001) 0.93
[Prevalence of osteoporosis assessed by densitometry in the Spanish female population]. Med Clin (Barc) (2001) 0.93
Selective vulnerability to kainate-induced oxidative damage in different rat brain regions. J Appl Toxicol (2001) 0.92
Atmospheric volatile organic compound measurements during the 1996 Paso del Norte Ozone Study. Sci Total Environ (2001) 0.92
TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis. Cell Death Differ (2012) 0.92
Haemoglobin Porto Alegre in a Cuban family. J Med Genet (1977) 0.90
Airway ignition during CO2 laser laryngeal surgery and high frequency jet ventilation. Eur J Anaesthesiol (2000) 0.87
[Epidemiologic study of Crohn's disease in the Asturian region]. Rev Esp Enferm Apar Dig (1983) 0.87
Nutritional intervention in early life to manipulate rumen microbial colonization and methane output by kid goats postweaning. J Anim Sci (2013) 0.87
Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass. Osteoporos Int (1998) 0.87
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. Osteoporos Int (2013) 0.87
[Results of studies performed in Cuba on hemoglobinopathy S]. Sangre (Barc) (1991) 0.86
Monte Carlo simulation describing the pharmacodynamic profile of cefditoren in plasma from healthy volunteers. Int J Antimicrob Agents (2008) 0.86
A patient with spiny keratoderma of the palms and a lymphoproliferative syndrome: an unrelated paraneoplastic condition? Dermatology (2000) 0.86
[Inflammatory pseudotumor of the larynx]. Acta Otorrinolaringol Esp (1999) 0.84
Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry (2001) 0.84
Evaluation of hematopoietic progenitors in hematopoietic progenitor cell transplants. CD34+ dose effect in marrow recovery. Retrospective analysis in 38 patients. Hematol Cell Ther (1999) 0.84
Clinical spectrum of extramedullary acute promyelocytic leukemia. Eur J Haematol (2000) 0.83
Increased leptin/adiponectin ratio and free leptin index are markers of insulin resistance in obese girls during pubertal development. Horm Res Paediatr (2013) 0.83
Two cases of hemoglobin New York in Costa Rica. Hemoglobin (1980) 0.82
[Factors influencing the immunization of children in the outpatient clinic of a pediatric hospital]. Bol Med Hosp Infant Mex (1992) 0.82
Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol (2007) 0.82
A second family with hemoglobin Willamette. Hemoglobin (1984) 0.81
Phototoxicity from nalidixic acid: oxygen dependent photohemolysis. Farmaco Sci (1987) 0.81
[Immunochemical differences in the surface polysaccharides obtained from Entamoeba histolytica strain HM1:IMSS and its virulent (C-A) and non-virulent (L-6) clones]. Arch Invest Med (Mex) (1990) 0.80
Enantiomeric separation of tramadol and its active metabolite in human plasma by chiral high-performance liquid chromatography: application to pharmacokinetic studies. Chirality (1999) 0.80
Differences in affinity of beta and delta hemoglobin chains for alpha chains. A possible explanation for the variation in the percentages of hemoglobin A2 in thalassemia and other disorders. Biochim Biophys Acta (1983) 0.79
The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy. J Endocrinol Invest (2011) 0.79
Haemoglobin J Guantanamo (alpha 2 beta 2 128 (H6) Ala replaced by Asp). A new fast unstable haemoglobin found in a Cuban family. Biochim Biophys Acta (1977) 0.79
Expression and immunological evaluation of the Escherichia coli-derived hepatitis C virus envelope E1 protein. Biotechnol Appl Biochem (2000) 0.79
Neonatal medium-chain acyl-CoA dehydrogenase deficiency presenting with very high creatine kinase levels. J Inherit Metab Dis (1998) 0.79
Acylated ghrelin levels in pre-pubertal obese children at diagnosis and after weight reduction: effect of oral glucose ingestion. J Endocrinol Invest (2010) 0.78
[Criptoccocosis: necessary warning]. Rev Cubana Med Trop (2005) 0.78
A sensitive method for the determination of gemfibrozil in human plasma samples by RP-LC. J Pharm Biomed Anal (2001) 0.78
[Hemoglobinopathy S with an interaction of HbS and Hb G-Ferrara]. Sangre (Barc) (1983) 0.78
[Clinical practice guideline on the management of patients with gastroesophageal reflux disease (GERD)]. Gastroenterol Hepatol (2002) 0.78
High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study. Int J Clin Pract (2008) 0.78
Urinary uroporphyrin as an indicator of arsenic exposure in rats. Proc West Pharmacol Soc (1983) 0.78
Hb Genova in a Cuban family. Clinical differences between carriers. Hemoglobin (1983) 0.77
Chemical characterization of a new haemoglobin variant haemoglobin J Cubujuqui (alpha2141(HC3)Arg replaced by Ser beta2). Biochim Biophys Acta (1977) 0.77
Proteinase activity in invasive cancer of the breast. Correlation with tumor progression. Arch Med Res (1995) 0.77
Comparative study of fermentation and methanogen community structure in the digestive tract of goats and rabbits. J Anim Physiol Anim Nutr (Berl) (2013) 0.77
High relative proportion of acute promyelocytic leukemia in children: experience of a multicenter study in Cuba. Leuk Res (2000) 0.76
Gestational diabetes in a Mexican-U.S. border population: prevalence and epidemiology. Rev Invest Clin (1996) 0.76
Hemoglobin variants in Cuba. Hemoglobin (1985) 0.76
Rapid liquid chromatographic assay for the determination of acetaminophen in plasma after propacetamol administration: application to pharmacokinetic studies. J Pharm Biomed Anal (1999) 0.76
Effect of Krebs cycle intermediates and inhibitors on toad gastric mucosa. Am J Physiol (1979) 0.76
Fosfomycin concentrations in epithelial lining fluid in weaning piglets. J Vet Pharmacol Ther (2011) 0.76
Effect of ethanol on dopamine synthesis and release from rat corpus striatum. Biochem Pharmacol (1976) 0.75
A study of the genetical structure of the Cuban population: red cell and serum biochemical markers. Am J Hum Genet (1976) 0.75
Possible interaction between cyclosporine and josamycin: a description of three cases. Clin Pharmacol Ther (1992) 0.75
[Inactivated antihepatitis A vaccine]. Rev Med Univ Navarra (1995) 0.75
[Control of antibiotic therapy in the Clinica Universitaria]. Rev Med Univ Navarra (1976) 0.75
[New pharmacologic agents: amlodipine++]. Rev Med Univ Navarra (1995) 0.75
[Metabolic radiotherapy in differentiated carcinoma of the thyroid]. Rev Med Univ Navarra (1984) 0.75
A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens. Chemioterapia (1987) 0.75
[Clinico-biological effectiveness of triflusal during the postoperative period of patients with chronic ischemic syndrome of the extremities]. Rev Med Univ Navarra (1981) 0.75
[Double-blind parallel clinical trial with tenoxicam in comparison with indomethacin in the treatment of rheumatoid arthritis]. Rev Med Univ Navarra (1984) 0.75
[A clinical report. Atypical subacute thyroiditis]. Rev Med Univ Navarra (1979) 0.75
A study of the delayed hypersensitivity response in healthy people in Spain: Spanish National Tables. National Surgical Infection Committee of the Association of Spanish Surgeons. JPEN J Parenter Enteral Nutr (1994) 0.75
[67gallium. Diagnostic possibilities and usefulness as a tracer]. Rev Med Univ Navarra (1984) 0.75
[Clinical experience with a new fluoroquinolone: ciprofloxacin]. Enferm Infecc Microbiol Clin (1989) 0.75
Fosfomycin in acute bronchopneumopathies. Chemotherapy (1977) 0.75
[Control of the quality of antibiotics and their i/v mixtures in large volume solutions]. Rev Med Univ Navarra (1976) 0.75
201Tl myocardial imaging in a cardiac rejection episode. Eur J Nucl Med (1986) 0.75
[5HT3 antagonists: ondansetron]. Rev Med Univ Navarra (1996) 0.75
[Indirect isotopic lymphography. Technic and clinical applications]. Rev Med Univ Navarra (1984) 0.75
[Minaprine]. Rev Med Univ Navarra (1984) 0.75
[Phase I study of a tolmetin-paracetamol (AU-8001) ester]. Rev Med Univ Navarra (1989) 0.75
[Ketorolac]. Rev Med Univ Navarra (2004) 0.75
[Consensus conferences: a form of rationalizing medical intervention]. Rev Clin Esp (1990) 0.75
[Principles of hospital antibiotic policy]. Rev Med Univ Navarra (1976) 0.75
Possible interaction between cyclosporine and josamycin. J Heart Transplant (1990) 0.75
[Control of adverse drug reaction in a hospital environment]. Rev Med Univ Navarra (1976) 0.75
Abdominal carcinomatosis secondary to ovarian carcinoma imaged by diphosphonate scanning. Clin Nucl Med (1985) 0.75
[Celiprolol]. Rev Med Univ Navarra (1991) 0.75
[Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia]. Rev Med Univ Navarra (1993) 0.75
The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report. Proc R Soc Med (1976) 0.75
[Pharmacologic surveillance outside the hospital: necessity and methods]. Rev Med Univ Navarra (1989) 0.75
[Functions of a hospital clinical pharmacology service]. Rev Med Univ Navarra (1988) 0.75
[Triflusal]. Rev Med Univ Navarra (1982) 0.75
[Functions of a clinical pharmacology hospital service]. Rev Med Univ Navarra (1991) 0.75
[Filgrastim: granulocyte colony stimulating factor]. Rev Med Univ Navarra (2004) 0.75
[Effectiveness and tolerance of norfloxacin compared with trimethoprim-sulfamethoxazole in the treatment of uncomplicated urinary tract infections]. Rev Med Univ Navarra (1989) 0.75